| Swiss Biotech in Ion Channel Research |
Anaxon is a Swiss ion channel analysis platform concentrating on the thorough implementation of safety and efficacy for a better molecule design in drug discovery. |
Mission: Strong emphasis is on the diversity of relevant ion channel alleles including their mutated variants. Founded as a spin-off company of the CHFO, Anaxon accomplishes research and development activities on a number of projects to learn more about the pathophysiology of channelopathies. |
Research: By means of it's assay matrix the company offers customized analysis concepts in ion channel drug discovery to selected sponsors and partners. |
Technology: Through it's proprietary diaFECT multi-cloning technology Anaxon designs highly standardized expression systems for the development of stable cell lines. Complex ion channel subunit combinations so far out of reach can be efficiently transfected in a modular approach. |
